Latest News and Press Releases
Want to stay updated on the latest news?
-
DURHAM, N.C. and COPENHAGEN, Denmark, Oct. 21, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), EPI Health, a Novan Company, and MC2 Therapeutics today announced...
-
DURHAM, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN) and EPI Health, a Novan Company, today announced that eight abstracts have been accepted for...
-
SARASOTA, Fla., Sept. 19, 2022 (GLOBE NEWSWIRE) -- In public relations, sometimes even the most newsworthy announcements can fall flat. There are many best practices to follow, according to various...
-
– New data analysis from previously completed successful Phase 3 study1 demonstrated WYNZORA® Cream to be effective and convenient for skin of color patients for the treatment of plaque psoriasis ...
-
NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Newswire, a media technology company and industry leader in press release distribution, announces that it is now offering Media Database subscriptions...
-
NEW YORK, Aug. 29, 2022 (GLOBE NEWSWIRE) -- The National Minority Supplier Development Council (NMSDC) is excited to announce the seventh consecutive cohort of Emerging Young Entrepreneurs (EYE)....
-
New York, Aug. 16, 2022 (GLOBE NEWSWIRE) -- The National Minority Supplier Development Council (NMSDC) is excited to announce that Dr. Sylvia Acosta has joined our executive leadership team as...
-
– Total revenue of $6.2 million for the second quarter 2022 – – Activities on track for submission of berdazimer gel, 10.3% (SB206) New Drug Application (NDA), targeting submission before the...
-
DURHAM, N.C., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its second quarter 2022 financial results on Thursday,...
-
New York, July 28, 2022 (GLOBE NEWSWIRE) -- The National Minority Supplier Development Council (NMSDC) is excited to announce that Kurtis Trevan has joined NMSDC as a consultant to fill the role of...